Grindeks invests 2.6 million euros in Quality Control Laboratory

Grindeks invests 2.6 million euros in Quality Control Laboratory


JSC Grindeks informs that its new Quality Control Laboratory was ceremonially opened today, on 5 June; it is one of the most advanced laboratories in the Baltics and meets world-class standards. The opening ceremony was attended by Prime Minister of Republic of Latvia Laimdota Straujuma, JSC Grindeks Chairman of the Council Kirovs Lipmans and JSC Grindeks Chairman of the Board Juris Bundulis, along with business partners and other guests.

lab atklasana

Prime Minister of Republic of Latvia Laimdota Straujuma and JSC Grindeks Chairman of the Council Kirovs Lipmans

The project was implemented in order to increase the productivity of microbiological and other analyses at the Quality Control Laboratory. Total project investments constituted 2.6 million euros, with 2.2 million euros in construction and 0.4 million euros in laboratory equipment and technical supply. The project was financed by the company’s funds.
The new laboratory will perform analyses of pharmaceuticals and develop and validate analytical methods in accordance with the Good Manufacturing Practices and ISO 9001, ISO 17025 and ISO 14001 standards.

JSC Grindeks Chairman of the Council Kirovs Lipmans: “Since 2002, investment in developing Grindeks has been substantial. We have invested a total of more than 70 million euros in developing our infrastructure and upgrading to state of the art technology, which has boosted the company’s operation and performance considerably. Today, we have completed the expansion and modernisation of our Quality Control Laboratory, which has been one of the most ambitious investment projects in quality control for Grindeks. The new laboratory will reinforce our company’s position and enhance the competitive performance.”

Having expanded its quality control range, Grindeks will also be providing analytical services to other companies in Latvia and abroad – required analyses of tablets, capsules, salves, gels, syrups, injections, active pharmaceutical ingredients, as well as validation of technology and cleaning, serial control and release of pharmaceutical products to EU and CIS markets.

JSC Grindeks Chairman of the Board Juris Bundulis: “As a pharmaceutical manufacturer, we are aware of our important mission to take care of people’s health – for this reason, the company has been continually improving its quality performance. Pharmaceutics is an industry where quality requirements become more demanding each year, and by opening the new Quality Control Laboratory we are going ahead of the curve. Furthermore, we now have the opportunity to offer our services to other businesses, both local and foreign.”

With the project fully implemented, the total area of the Quality Control Laboratory is 1670 m² (755 m² of which were renovated). The laboratory now features a highly advanced automated control system for controlling the indoor microclimate and operation of utility systems, which will yield considerable energy savings. State of the art equipment will ensure that lab analyses are conducted in a convenient, safe, efficient and environmentally friendly manner.

Related posts


Grindeks celebrates 75-year anniversary

Today on December 21, JSC Grindeks, the leading pharmaceutical manufacturer in the Baltic States celebrates its 75-year anniversary. Over these 75 years, Grindeks has become...